Allan Jonathan sold STOK
August 13, 2025 · Form 4 insider transaction
Allan Jonathan sold 13,712 shares of Stoke Therapeutics, Inc. at $15.00 per share, a transaction worth $205.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
13,712
Price
$15.00
Total value
$205.7K
InsiderAllan Jonathan
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2025
Filing dateAugust 15, 2025
Shares owned after19,631
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.; The reported total includes an aggregate 1,778 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d).